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Background: Several studies have reported an association between chronic periodontitis (CP) and cardio-
vascular diseases. Detection of periodontopathogens, including red complex bacteria (RCB), in vascular
lesions has suggested these bacteria to be involved in the pathogenesis of atherosclerosis and abdominal aortic
aneurysms.
Objective: In this study, we investigate bacteria and their DNA in vascular biopsies from patients with
vascular diseases (VD; i.e. abdominal aortic aneurysms, atherosclerotic carotid, and common femoral
arteries), with and without CP.
Methods: DNA was extracted from vascular biopsies selected from 40 VD patients: 30 with CP and 10
without CP. The V3-V5 region of the 16S rDNA (V3-V5) was polymerase chain reaction (PCR)-amplified,
and the amplicons were cloned into Escherichia coli, sequenced, and classified (GenBank and the Human
Oral Microbiome database). Species-specific primers were used for the detection of Porphyromonas gingivalis.
In addition, 10 randomly selected vascular biopsies from the CP group were subjected to scanning electron
microscopy (SEM) for visualization of bacteria. Checkerboard DNADNA hybridization was performed to
assess the presence of RCB in 10 randomly selected subgingival plaque samples from CP patients.
Results: A higher load and mean diversity of bacteria were detected in vascular biopsies from VD patients
with CP compared to those without CP. Enterobacteriaceae were frequently detected in vascular biopsies
together with cultivable, commensal oral, and not-yet-cultured bacterial species. While 70% of the subgingival
plaque samples from CP patients showed presence of RCB, only P. gingivalis was detected in one vascular
biopsy. Bacterial cells were seen in all 10 vascular biopsies examined by SEM.
Conclusions: A higher bacterial load and more diverse colonization were detected in VD lesions of CP
patients as compared to patients without CP. This indicated that a multitude of bacterial species both from
the gut and the oral cavity, rather than exclusively periodontopathogens, may be involved as additional risk
factors in the pathogenesis of VD.
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C
hronic periodontitis (CP) and atherosclerotic and
abdominal aortic aneurysmal vascular disease
(VD) are highly prevalent, chronic inflammatory
conditions with complex and multifactorial etiology. CP
is initiated by the accumulation of dental plaque with a
subsequent gingival inflammatory immune response that
may progress to the destruction of connective tissue and
alveolar bone (1). Atherosclerosis is characterized by
initial endothelial injury followed by invasion of macro-
phages, accumulation of lipids, and calcification of the
subendothelial layer, and can cause disabling and life-
threatening conditions such as myocardial infarction
and stroke (2). The mechanisms causing the initiation
and progression of the abdominal aortic aneurysm are
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poorly understood. Inflammation, matrix degradation,
and thrombosis formation are important features of the
disease, which is a significant cause of morbidity and
mortality in the adult population (3).
Traditional risk factors such as smoking, hypercholes-
terolemia, hypertension, and diabetes mellitus cannot
fully account for the overall incidence of VD (4). Chronic
bacterial infections such as periodontitis are suggested to
be additional risk factors (58).
The gingival epithelium is part of the innate immune
system acting as a physical barrier against invasion of
oral bacteria. In the oral cavity, approximately 700 dif-
ferent major bacterial species have been identified by
16S rDNA sequencing, and more than 400 species are
identified from periodontal pockets (9). In sites with
active periodontal disease, the epithelial barrier is ulcer-
ated and discontinuous and may allow dissemination of
oral bacteria into the underlying connective tissue and
capillaries, and eventually into the systemic circulation.
Transient bacteremias in patients with periodontitis have
been detected after regular activity such as tooth brush-
ing and following periodontal treatment (1012). Direct
hematogenous spreading of oral bacteria and invasion of
endothelial and smooth muscle cells are considered to be
the main mechanisms of the association between period-
ontitis and cardiovascular diseases. In addition, oral
bacteria may also reach the arterial walls by invading
phagocytic cells (6, 13).
Several studies have identified periodontopathogens
such as Porphyromonas gingivalis and Treponema denticola
in atherosclerotic lesions (1417). In vitro studies and in
vivo animal studies have shown that bacteria associated
with periodontal disease, such as P. gingivalis, may con-
tribute to vascular inflammation by several mechanisms
such as activation of toll-like receptors, increasing the
production of pro-inflammatory mediators, and the
expression of cell-surface adhesion molecules, causing
apoptosis of vascular cells, and triggering of the coagula-
tion cascade (6, 13). Using quantitative polymerase chain
reaction (PCR), Gaetti-Jardim et al. demonstrated that
periodontopathic bacterial DNA represented 47.3% of
the total bacterial DNA found in atheromatous samples
from patients with periodontitis and 7.2% of the total
bacterial DNA detected in atheromas from periodontally
healthy subjects (18). Ott et al. (19) reported an overall
high bacterial diversity with more than 50 bacterial
species in the coronary atherosclerotic tissue using 16S
rDNA clone libraries. These and other studies suggest
that a multitude of bacterial species may contribute to
atherogenesis and abdominal aortic aneurysm formation
(5, 20, 21).
The objective of this case-control study was to
investigate the bacterial diversity in atherosclerotic pla-
que and aneurysmal wall biopsies from patients with
and without CP by sequencing 16S rDNA clone libraries.
In addition, the presence of P. gingivalis in VD biopsies
from CP patients was investigated using species-specific
PCR and subsequent sequencing. Scanning electron micro-
scopy (SEM) was used to visualize bacterial cells in VD
lesions.
Material and methods
Participants
This study included a total of 77 patients with VD who
were recruited at the Department of Vascular Surgery,
Oslo University Hospital, Aker, Oslo, Norway. They were
scheduled for vascular surgery, including abdominal
aortic aneurysm repair and carotid or femoral arterial
endarterectomy. Clinical oral examinations were per-
formed at the hospital ward to determine the periodontal
status of the patient.
The patients were categorized into two groups accord-
ing to their clinical periodontal status. The first group (VD
with CP, n30) were patients undergoing treatment for
VD and who were diagnosed with CP. The second group
(VD without CP, n47) were patients undergoing treat-
ment for VD and who were assessed without periodontitis.
The patients’ medical records were obtained for general
health information. Questions on ethnicity and smok-
ing behavior were self-reported. Written informed con-
sent was obtained from all participants. This study was
approved by the Regional Ethical Committee (REK Sør,
NO. 08/322b) and was in accordance with the Helsinki
declaration of 1975, as revised in 1983. This study has
been registered at ClinicalTrials.gov (ID. NCT01358630).
Inclusion criteria
The patients in both groups were diagnosed and treated
according to standard procedures at the Department of
Vascular Surgery, Oslo University Hospital, Aker. Diag-
nosis of CP was based on the classification system of the
American Academy of Periodontology, established in
1999 at the International Workshop for Classification of
Periodontal Diseases and Conditions (22). Clinical per-
iodontal status was assessed by periodontal pocket
probing depth and bleeding on probing. The measure-
ments were done at the mesial, buccal, distal, lingual, and
palatinal surfaces of all teeth. Subjects who had at least
four sites with a probing depth ]5 mm and bleeding on
probing were categorized as having CP. All periodontal
examinations were done by an experienced dentist. No
subject had received periodontal treatment within the last
6 months or taken antibiotics within the past month.
Sample collection and DNA extraction
Vascular tissue biopsies and subgingival plaque samples
were collected for extraction of genomic DNA and
checkerboard DNADNA hybridization analysis, respec-
tively. The vascular biopsies were collected under surgical
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treatment from the walls of aneurysms and during exci-
sion of intravascular plaques in carotid or common femo-
ral arteries. The biopsies were immediately transferred
from bedside to a sterilized container that was brought
on ice to the laboratory and stored at 808C. The collec-
tion of the biopsies and further processing in the labo-
ratory were performed under strict aseptic conditions.
Extraction of genomic DNA was done by using the
Masterpure Complete DNA Purification Kit (Epicentre
Biotechnologies, Madison, WI), according to the manu-
facturer’s extraction protocol for tissue samples with
some modifications.
In order to make a representable selection of the biop-
sies for DNA extraction and assist cell lysis, the vascular
biopsies were mechanically homogenized. Proteinase K
(100 mg) was used for cell lysis treatment. After the
samples were treated with RNase A (5 mg) and protein-
precipitated, they were kept in 0.5 M NaCl. Further, they
were purified with (1:1 v/v) phenolchloroform (VWR
International AS, Oslo, Norway) and centrifuged in
Phase Lock Gel tubes (5Prime, Gaithersburg, MD). The
aqueous phase was treated twice with chloroform iso-
amyl alcohol (1:1 v/v) (AppliChem GmbH, Darmstadt,
Germany). DNA was precipitated with 100% ethanol
(Kemetyl, Vestby, Norway) in 0.3 M sodium acetate
(AppliChem GmbH). The pellet was washed twice with
75% ethanol, resuspended in 1TE buffer (10 mM Tris,
1 mM EDTA, pH 8.0) and stored at 208C.
Negative and positive control reactions were per-
formed for the tissue homogenization and DNA extrac-
tion methods.
The subgingival plaque samples were collected from
four periodontal sites for each subject. In patients with
CP, the deepest pockets with bleeding on probing were
chosen, while in patients without CP, four sites were
chosen randomly. After removal of supragingival plaque,
isolation, and drying of sample sites with cotton rolls,
subgingival plaque was collected by using sterile Gracey
curettes. Samples were pooled and transferred to tubes
containing 300 ml TE buffer.
PCR amplification of bacterial DNA
Universal bacterial primers were used for 16S rDNA ampli-
fication under standardized conditions with forward
primer: E334F 5?-CCAGACTCCTACGGGAGGCAGC-
3? and reverse primer: E939R 5?-CTTGTGCGGGCCC
CCGTCAATTC-3? (23). These primers cover the hyper-
variable region V3-V5 of the 16S rRNA gene, have
high specificity to bacterial sequences, and low match
to Eukarya and Archaea sequences (23). PCRs were
performed with Accuprime Supermix II (Invitrogen,
Carlsbad, CA) at an annealing temperature of 698C and
a total of 32 cycles.
Species-specific PCR assays and fimA genotyping were
applied for the identification of the periodontopathogen
P. gingivalis in vascular biopsies from patients with CP.
The previously reported primers for P. gingivalis 16S
rRNA and fimA gene (24, 25) were used (Table 1). PCRs
were performed with OneTaq 2X Master Mix with
standard buffer (New England Biolabs, Beverly, MA)
and annealing temperatures as given in Table 1.
Each set of experiments included negative controls
with sterile molecular grade water instead of template
DNA and positive controls containing purified DNA
from Veillonella dispar, P. gingivalis strains for fimA type I
(ATCC 33277T) and fimA type II (A7A1-28). The PCR
products were detected by 1% agarose gel electrophoresis.
Gels were stained with ethidium bromide, using 1Kb Plus
DNA Ladder (Invitrogen).
Cloning and sequencing
The universal 16S rDNA PCR amplicons (primers E334/
E939) were ligated into the pCR4-TOPO vector using
the TOPO TA cloning kit (Invitrogen) and transformed
into competent Escherichia coli TOP10 cells according
to the manufacturer’s instructions. Ninety-six colonies
were collected from each sample to make a representative
library of the PCR products, which were stored in the
TE buffer at 208C until further processing. After PCR
amplification of the inserts with M13 forward primer, 5?-
GTA AAA CGA CGG CCA G-3?, and M13 reverse
primer, 5?-CAG GAA ACA GCT ATG AC-3?, the PCR
Table 1. Porphyromonas gingivalis 16S rDNA and fimA gene-specific primers used in this study
Primer set Sequence (5?-3?) Annealing (8C) Amplicon size (bp)
P. gingivalis 16S rDNA TGT AGA TGA CTG ATG GTG AAA ACC
ACG TCA TCC CCA CCT TCC TC
608C 197
M11/M12 fimA AATCTGAACGAACTGCGACGCTAT
CTCCCTGTATTCCGAATATAGAC
558C 1,300
Type I fimA CTG TGT GTT TAT GGC AAA CTT C
AAC CCC GCT CCC TGT ATT CCG A
588C 392
Type II fimA ACA ACT ATA CTT ATG ACA ATG G
AAC CCC GCT CCC TGT ATT CCG A
508C 257
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products were purified by Exosap-IT (Affymetrix, Santa
Clara, CA) according to the manufacturer’s protocol.
Purified amplicons were sequenced using the BigDye
Terminator v1.1 Cycle Sequencing Kit (Applied Biosys-
tems, Foster City, CA) and the M13 forward primer.
The P. gingivalis-specific PCR amplicons were se-
quenced using the BigDye terminator v1.1 Cycle Sequen-
cing Kit according to the manufacturer’s instructions
and the respective forward primers (Table 1). Sequence
reactions were run on an ABI Prism 3,730 DNA analyzer
(Applied Biosystems).
Data analysis of the sequences
Sequence trimming and quality check were performed
with the Sequencher 5.0 program (Gene Codes Corp.,
Ann Arbor, MI). The UCHIME program (26) at the
mothur platform (27) was used for chimeric check. After
the elimination of suspected chimeric sequences, the 16S
rDNA sequences (500 bp) were used to determine
bacterial identity. The sequences were aligned by using
the Molecular Evolutionary Genetics Analysis (MEGA)
software version 5 (28).
For identification of closest relatives, the consensus
sequences were compared with known sequences in the
GenBank databases using the NCBI BLAST search tool
(http://www.ncbi.nlm.nih.gov/BLAST/) and Human Oral
Microbiome Database (HOMD; http://www.homd.org/)
(29).
Checkerboard DNADNA hybridization
Ten randomly selected subgingival plaque samples from
VD patients with CP were assessed for the presences of
red complex bacteria (RCB) using checkerboard DNA
DNA hybridization. NaOH (100 ml of 0.5 M) was added
to 100 ml of subgingival plaque samples in TE buffer
and vortexed. After boiling for 10 min, 800 ml of 5 M
ammonium acetate was added to neutralize the samples.
The DNA was then applied into the extended slots of a
Minislot-30 apparatus (Immunetics, Cambridge, MA)
with a positively charged nylon membrane (Boehringer
Mannheim, Indianapolis, IN). The membrane had two
lanes with DNA standards equivalent to 105106 cells per
target species tested. The membranes were hybridized
with 20 digoxigenin labeled whole genome probes of
species significant for the subgingival microbiota, includ-
ing RCB (Table 2) (30). DNA from the type species was
used as probes.
Scanning electron microscopy
Ten randomly selected vascular biopsies from VD
patients with periodontitis were selected at random for
SEM. The biopsies were cut into blocks of approximately
55 mm. Tissue blocks were fixed in 2.5% glutaralde-
hyde or 0.1 mol/L Sorensen phosphate buffer, and stored
at 48C until processing. After dehydration in ethanol, the
blocks were critically point-dried with carbon dioxide.
The specimens were finally sputter-coated with gold or
palladium in a vacuum evaporator and examined in a
scanning electron microscope (XL 30 ESEM; Philips,
Eidenhoven, The Netherlands) (31).
Statistical analyses
The statistical analyses were performed using the SPSS
software (IBM SPSS Statistic version19). Independent
samples t-tests were used for comparisons of species
diversity and bacterial load between the two groups. For
comparisons of demographic data between the two
groups, independent t-test and Fisher’s exact test were
performed. A statistically significant difference was de-
fined with pB0.05.
Results
This study included a total of 77 patients with VD. They
were categorized into two groups according to their
clinical periodontal status. The first group (VD with
CP) were patients undergoing treatment for VD and who
Table 2. Bacterial species detected by DNADNA hybridi-
zation (checkerboard analysis) in subgingival dental plaque
samples from patients with atherosclerotic and abdominal
aortic aneurysmal vascular disease and chronic periodontitis
Detection frequency in
subgingival dental plaque
samples (n10)
Fusobacterium nucleatum ssp.
vincentii
1.0
Eubacterium saburreum 1.0
Prevotella nigrescens 0.9
Actinomyces viscosus 0.8
Actinomyces gerencseriae 0.8
Actinomyces israelii 0.7
Streptococcus intermedius 0.7
Porphyromonas gingivalis 0.7
Fusobacterium nucleatum ssp.
polymorphum
0.6
Fusobacterium nucleatum ssp.
nucleatum
0.6
Tannerella forsythia 0.6
Aggregatibacter
actinomycetemcomitans
0.4
Treponema denticola 0.4
Porphyromonas endodontalis 0.4
Campylobacter rectus 0.2
Treponema socranskii ssp.
socranskii
0.2
Prevotella melaninogenica 0.2
Eikenella corrodens 0.2
Parvimonas micra 0.1
Prevotella intermedia 0.0
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were diagnosed with CP (n30, mean age66.9, stan-
dard deviation (SD)7.9, range: 51.385.0, male25/30
(83%)). The second group (VD without CP) were patients
undergoing treatment for VD and who were assessed
without periodontitis (n47, mean age70.9, SD9.7,
range: 45.784.8, male37/47 (79%)). Vascular biopsies
from all 30 VD patients with CP and 10 randomly
selected VD patients without CP were further analyzed
for detection of 16S rDNA sequences. In total, 27 biop-
sies from abdominal aortic aneurysmal walls, 9 from
carotid, and 4 from common femoral atherosclerotic
plaque were examined. Demographic data of the two
study groups are presented in Table 3. The patients
with CP had significantly higher number of periodontal
pockets with probing depth ]5 mm (pB0.01). They also
had a significantly higher pack-year smoking history
(pB0.01). There was no significant difference in terms of
age, gender, diabetes, body mass index, and number of
teeth between the two groups.
After discarding incomplete sequences, a total of 2,638
sequences from VD patients with CP and 859 sequences
from VD patients without CP were analyzed. A sequence
similarity threshold of ]97 and ]99% were applied for
identification at the genus and species level, respectively
(32). Sequences with similarity lower than 97% were
ranked as unclassified and were excluded (listed accord-
ing to the closest relative in Supplementary file SA). After
optimization of the PCR, weak PCR bands were detected
in the negative PCR controls (50%) and were subse-
quently sequenced. These background sequences (Sup-
plementary file SB) as well as eukaryote and chimeric
sequences were also discarded from the sequences ob-
tained from the vascular samples and further analyzed. A
final total of 38 out of 40 (95%) vascular samples with
bacterial DNA were subjected to further analysis.
After discarding unwanted sequences, the final fraction
of bacterial sequences, reflecting overall bacterial load,
obtained from the vascular biopsies in patients with CP
was in average 68923% (range: 098%) at an individual
level. In patients without CP, this fraction was signifi-
cantly lower with an average of 25926% (range: 084%;
pB0.01). No significant difference in bacterial load was
found comparing intravascular plaque versus aneurysmal
vascular biopsies in any group.
Eighty-four different bacterial taxa were detected from
a total of 1,808 sequences from the VD patients with
CP (Table 4). From the VD patients without CP, 18 dif-
ferent taxa were identified from a total of 210 sequences
Table 3. Demographic data of the study groups with atherosclerotic and abdominal aortic aneurysmal vascular disease (VD),
with and without chronic periodontitis (CP)
VD with CP VD without CP
n30 n10 p
Age
Mean9SD 66.997.9 68.4910.2 0.66
Median (range) 66.6 (51.385.0) 69.1 (48.983.6)
Gender (n) 1.00*
Male 25 8
Female 5 2
Teeth (n)
Mean9SD 19.197.0 19.699.2 0.87
Median (range) 20 (427) 23.5 (228)
Periodontal pocket probing depth (n]5 mm)
Mean9SD 17.9911.8 0.590.97 B0.01
Median (range) 15.5 (455) 0 (03)
Diabetes (n) 0.15*
1 2
Smoking (n)
Non-smokers 1 3
Current or previous smokers 29 7
Pack-year Mean9SD 36.4920.3 19.4911.4 B0.01
Pack-year Median (range) 34.2 (4.988.0) 17.3 (5.251.3)
BMI (kg/m2)
Mean9SD 26.494.2 27.794.2 0.43
Median (range) 26.4 (14.235.3) 26.3 (22.637.0)
*Based on a Fisher’s exact test.
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Table 4. Bacterial taxa identified in atherosclerotic plaque and abdominal aortic aneurysmal wall biopsies from patients with
chronic periodontitis
16S rDNA sequence frequency
(total n1,808)
n vascular biopsies positive
(total n30)Closest relative n %
1. Serratia sp.* 251 13.9 15
2. Propionibacterium acnes*** 229 12.7 21
3. Pseudomonas sp.** 179 9.9 11
4. Acinetobacter sp.** 108 6.0 11
5. Phenylobacterium sp. 79 4.4 8
6. Uncultured Firmicutes bacterium 79 4.4 10
7. Flavobacterium sp. 60 3.3 6
8. Uncultured unclassified bacterium**** 44 2.4 7
9. Uncultured Actinobacterium 31 1.7 3
10. Bacillus sp.*** 30 1.7 2
11. Staphylococcus petenkoferri** 28 1.5 1
12. Chitinophagaceae bacterium 28 1.5 1
13. Corynebacterium sp.** 27 1.5 5
14. Klebsiella sp.* 27 1.5 5
15. Streptococcus sp.** 25 1.4 4
16. Dietzia sp. 24 1.3 3
17. Bradyrhizobium sp. 23 1.3 3
18. Enterococcus sp. 22 1.2 3
19. Uncultured Rhodobacteraceae bacterium 22 1.2 3
20. Microbacterium sp. 21 1.2 4
21. Moraxella osloensis 21 1.2 2
22. Uncultured Geobacter sp. 20 1.1 1
23. Staphylococcus epidermidis** 19 1.1 2
24. Ralstonia picketti** 18 1.0 2
25. Burkholderia sp.** 14 0.8 5
26. Pedobacter sp. 14 0.8 2
27. Alishewanella sp. 13 0.7 2
28. Stenotrophomonas maltophilia 13 0.7 2
29. Kytococcus sedentarius 12 0.7 1
30. Oxalobacteraceae bacterium 12 0.7 1
31. Sediminibacterium sp. 12 0.7 1
32. Acinetobacter bereziniae** 11 0.6 2
33. Afipia sp. 11 0.6 2
34. Alloprevotella sp. 11 0.6 1
35. Capnocytophaga sputigena 11 0.6 1
36. Micrococcus sp. 11 0.6 1
37. Uncultured Flavobacterium sp 11 0.6 1
38. Hymenobacter roseosalivarius** 10 0.6 1
39. Rhizobium sp. 10 0.6 1
40. Uncultured Oxalabacteriacae bacterium 10 0.6 1
41. Caulobacter sp. 9 0.5 1
42. Friedmanniella sp. 9 0.5 2
43. Nocardioides sp. 9 0.5 3
44. Staphylococcus sp.** 9 0.5 1
45. Adhaeribacter sp. 8 0.4 1
46. Blastococcus sp. 8 0.4 1
47. Streptomyces sp. 8 0.4 1
48. Massilia sp. 7 0.4 2
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(Table 5). The relative abundance of the different taxa
detected in vascular biopsies from patients with and
without CP is presented in Tables 4 and 5, respectively.
The mean diversity of bacterial taxa detected from the
vascular biopsies was significantly higher in patients with
CP (n30), average of 7.193.2 (range: 012), compared
to those without CP (n10), average of 2.891.6 (range:
05; pB0.01). No significant difference in mean bacterial
diversity was found comparing intravascular plaque
versus aneurysmal vascular biopsies in any group.
Patients with CP displayed a wide variety of bacteria
identified at the genus level from their vascular biop-
sies, including some known oral bacterial taxa (e.g. Stre-
ptococcus spp., Prevotella sp., and Capnocytophaga sp.).
Table 4 (Continued )
16S rDNA sequence frequency
(total n1,808)
n vascular biopsies positive
(total n30)Closest relative n %
49. Ornithinimicrobium sp. 7 0.4 1
50. Uncultured Gallionella sp. 7 0.4 1
51. Acidovorax sp. 6 0.3 3
52. Actinomyces oris 6 0.3 2
53. Carnobacterium sp. 6 0.3 1
54. Peptoniphilus tyrrelliae 6 0.3 1
55. Psychrobacter sp. 6 0.3 2
56. Rhodoplanes sp. 6 0.3 1
57. Roseinatronobacter sp. 6 0.3 1
58. Uncultured beta Proteobacteria 6 0.3 1
59. Brevundimonas sp. 5 0.3 1
60. Comamonas sp. 5 0.3 1
61. Facklamia tabacinasalis 5 0.3 2
62. Thermoanaerobacterium sp. 5 0.3 1
63. Veillonella dispar 5 0.3 1
64. Uncultured Chitinophaga sp. 5 0.3 1
65. Uncultured Elusimicrobium sp. 5 0.3 1
66. Aerococcus sp. 4 0.2 1
67. Porphyromonas gingivalis 4 0.2 1
68. Rhodococcus sp. 4 0.2 1
69. Tepidimonas sp. 4 0.2 1
70. Uncultured delta Proteobacterium 4 0.2 1
71. Agrococcus terreus 2 0.1 1
72. Alphaproteobacteria 2 0.1 1
73. Aquabacterium sp. 2 0.1 1
74. Delftia acidovorans 2 0.1 1
75. Lysinibacillus sp. 2 0.1 1
76. Massilia haematophila 2 0.1 1
77. Roseococcus sp. 2 0.1 1
78. Roseomonas aquatica 2 0.1 1
79. Staphylococcus aureus** 2 0.1 1
80. Cellulomonas sp. 1 0.1 1
81. Corynebacterium afermentans** 1 0.1 1
82. Streptococcus sanguinis** 1 0.1 1
83. Streptococcus salivarius** 1 0.1 1
84. Undibacterium sp. 1 0.1 1
The different taxa were identified by NCBI BLAST analysis using a similarity threshold of ]97% for identification
Possible overlap with bacterial taxa identified in vascular biopsies from VD patients without CP at *family, **genus, ***species, and
****unranked levels.
Bacterial taxa underlined are listed among the human oral microbial taxa in Human Oral Microbiome Database (HOMD).
Periodontitis and cardiovascular diseases
Citation: Journal of Oral Microbiology 2014, 6: 23408 - http://dx.doi.org/10.3402/jom.v6.23408 7
(page number not for citation purpose)
Members of the Enterobacteriaceae family (e.g. Serratia sp.
and Klebsiella sp.) were also frequently identified in this
group (Table 4). Pseudomonas sp. and Propionibacterium
acnes were abundant in both groups of patients. Stre-
ptococcus, Staphylococcus, and Acinetobacter spp. were
also detected in both groups and were among the
most prevalent species in the VD group with CP. In
total, 15% and 4.3% of the sequences were identified as
not-yet-cultured bacterial spp. in the VD group with
and without CP, respectively. Environmental species, e.g.
Phenylobacterium and Bradyrhizobium spp., were also
identified.
Using universal bacterial 16S rDNA PCR, P. gingivalis
was detected in the vascular biopsy from only one VD
patients with CP. No other members of the RCB were
detected from the vascular biopsies in either group. None
of the 30 vascular biopsies from VD patients with CP
were positive for P. gingivalis using the specific primers
listed in Table 1. Weak PCR bands were detected in the
vascular samples using the fimA II primer set. Sequencing
these bands showed non-specific binding of primers to
human DNA. However, checkerboard analysis revealed
presence of one to three members of the RCB species in
7 out of 10 subgingival plaque samples from the CP
patients (Table 2).
Ten vascular biopsies from VD patients with CP were
randomly selected for SEM. Cocci and rod-shaped
bacterial cells of different sizes were seen in all biopsies
(Fig. 1af). Bacteria were observed at the surface of the
intravascular plaque lining the arterial lumen entangled
in a meshwork of delicate fibers and plaque remnants.
Several preparations from each biopsy were inspected in
order to visualize bacterial cells. Most often, the bacterial
cells were found coaggregated as micro-colonies at a
distance from each other. The coaggregated bacteria in
each location were most often of uniform morphology.
Apparent bacterial cell division with invagination of the
cell membrane was seen in some of the SEM images.
Discussion
Bacterial DNA was detected in 95% of the vascular
biopsies, and most biopsies contained DNA from multi-
ple bacterial species, pointing to a less specific relation-
ship between single species and VD. These findings are
supported by recent studies suggesting multiple bacterial
species being involved in cardiovascular diseases (5, 21).
Table 5. Bacterial taxa identified in atherosclerotic plaque and abdominal aortic aneurysmal wall biopsies from patients without
chronic periodontitis
16S rDNA sequence
frequency
(Total n210) n vascular biopsies positive
Closest relative* n % (Total n10)
1. Bacillus idriensis 44 21.0 1
2. Pseudomonas sp. 35 16.7 5
3. Delftia sp. 20 9.5 1
4. Ralstonia sp. 18 8.6 2
5. Corynebacterium sp. 15 7.1 1
6. Propionibacterium acnes 15 7.1 3
7. Mycobacterium sp. 12 5.7 1
8. Salinicoccus sp. 10 4.8 1
9. Burkholderia sp. 9 4.3 2
10. Hymenobacter sp. 6 2.9 2
11. Uncultured unclassified bacteria 6 2.9 1
12. Streptococcus sp. 5 2.4 2
13. Staphylococcus sp. 4 1.9 1
14. Uncultured Bacteroidales bacterium 3 1.4 1
15. Paracoccus sp. 3 1.4 1
16. Acidobacteria bacterium 2 1.0 1
17. Enterobacteriaceae bacterium 2 1.0 1
18. Acinetobacter sp. 1 0.5 1
The different taxa were identified by NCBI BLAST analysis using a similarity threshold of ]97% for identification.
Possible overlap with bacterial taxa identified in vascular biopsies from VD patients with CP is highlighted in bold.
Bacterial taxa underlined are listed among the human oral microbial taxa in Human Oral Microbiome Database (HOMD).
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We detected a significantly higher mean diversity and
a higher load of bacteria in the vascular biopsies from
the CP group as compared to the group without CP.
In patients with CP, the defective epithelial barrier of the
periodontal pockets together with a high load and
diversity of bacteria in the subgingival plaque make it
conceivable that the oral ‘gateway’ is contributing to the
bacterial composition detected in VD biopsies. Bacterial
translocation and transient bacteremia are caused by
dental procedures, oral infections, and may even follow
tooth brushing and chewing (10). Blood-borne micro-
organisms are usually cleared by the immune system
within minutes. However, favorable conditions may allow
colonization at a given site, as seen in cases of infective
endocarditis (33).
Even though RCBs were detected at high frequencies in
the subgingival plaque samples, only P. gingivalis was
identified from only one vascular biopsy from a patient
with CP. In addition, we used P. gingivalis-specific
primers; however, none of these primers yielded positive
detection of P. gingivalis in our VD biopsies. Similarly,
several other studies, using species-specific PCR, nested
PCR and hybridization detection techniques, also re-
ported no detection of RCB in atherosclerotic carotid
lesions, despite the presence of one or more period-
ontopathogens in the patients’ subgingival plaque sam-
ples (3436). A possible explanation to the negative or
sparse detection of RCB in VD biopsies may be that, in
contrast to commensal bacteria, ‘more antigenic’ mi-
crobes such as the RCB are readily recognized by the
immune system and eliminated from the circulation. In a
study by Nakano et al. (37), Streptococcus mutans strains
serotype k survived in blood for a longer time due to
lower antigenicity as compared to more cariogenic strains.
In addition, a variation in ability to invade cardiovascular
cells has been demonstrated among different P. gingivalis
strains (38). Similar invasive heterogeneity is reported for
Aggregatibacter actinomycetemcomitans and S. mutans
strains (39, 40). Individual differences in harboring
invasive strains may be an alternative explanation of
the discrepancies in the detection of RCB in vascular
tissue reported in the literature (11).
Nevertheless, many studies have reported the presence
of periodontopathogens in atherosclerotic lesions from
aorta, coronary, carotid, and femoral arteries (14, 16, 17,
41), although with variable frequency (11, 36). These
variations may be due to methodological differences, e.g.
origin of specimens, DNA extraction techniques, the use
of specific or universal primers, and PCR conditions (14,
35). However, even by using similar PCR-based techni-
ques with the same specific primers, various detection
rates for RCB (032% for P. gingivalis) in peripheral
a) b) c)
d) e) f)
Fig. 1. Scanning electron micrographs of bacteria in vascular biopsies from patients with periodontitis. (a) Area of aneurysmal
wall with bacteria entangled in meshwork of delicate fibers. (b) Area of aneurysmal wall with bacteria entangled in meshwork of
delicate fibers and remnants of intravascular plaque on aneurysmal wall. (c) Microorganisms (rods) with remnants of
intravascular plaque on aneurysmal wall. (d) Area of aneurysmal wall with bacteria entangled in meshwork of delicate fibers and
remnants of intravascular plaque on aneurysmal wall. (e, f) Area of aneurysmal wall with coccus-shaped bacteria entangled in
meshwork of delicate fibers and remnants of intravascular plaque on aneurysmal wall. Apparently, division of coccus-shaped
bacteria is occurring.
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atherosclerotic biopsies from patient with CP have been
reported (41, 42). With the P. gingivalis fimA II primer set
previously used for P. gingivalis detection in cardiovas-
cular specimen (43), weak PCR bands were detected in
some of our vascular samples. Sequencing of these bands
showed non-specific binding of primers to human DNA.
These findings together with the human sequences
identified, using bacterial-specific 16S rDNA primers,
emphasize the importance of identifying PCR products
by sequencing in studies involving specimens where
bacterial DNA is sparse. Using nested PCR and sequen-
cing, Fiehn et al. (44) reported a detection rate of 4.17%
for P. gingivalis in carotid and femoral atherosclerotic
biopsies. None of the other members of the RCB were
detected. Ott et al. (19) found an overall high bacterial
diversity with more than 50 bacterial species in coronary
atherosclerotic tissue using 16S rDNA clone libraries;
however, they did not detect any members of RCB. By
using 454 high-throughput sequencing, Koren et al.
(45) also could not confirm the presence of DNA from
periodontopathogens in carotid artery biopsies. Sparse
finding of RCB in abdominal aneurysmal samples
(Tannerella forsythia in 1 out of 10 samples) was also
reported in a study by Marques da Silva et al. using 16S
rRNA PCR and sequencing (31). DNA from none of the
other RCB was detected. However, the DNA of period-
ontopathogens was detected in the atheromatous plaques
from coronary arteries in a Chinese population with
CP (46). The prevalence of T. forsythia, Fusobacterium
nucleatum, Prevotella intermedia, and P. gingivalis was 31,
12, 18, and 33%, respectively. The same specific primers
for T. forsythia, F. nucleatum, and P. intermedia were used
by Cairo et al. (35) for investigating carotid atheromatous
plaque for bacterial DNA. They were not able to detect
DNA from these species, even though dental plaque
samples were positive in 79, 63, and 53% of the cases,
respectively.
Although we were able to detect bacterial DNA in
most VD biopsies, the bacterial load was generally sparse
as reflected by the amount of PCR products obtained.
Also, with SEM several preparations from each biopsy
had to be inspected in order to visualize bacterial cells.
Most often the bacterial cells were found coaggregated
in intravascular plaque lining the arterial lumen. Due
to scant amounts of PCR products, several rounds of
cloning and sequencing had to be performed to obtain 96
clone libraries with sequences of adequate quality and
size, especially when processing VD biopsies from
patients without periodontitis. In these patients, the final
fraction of bacterial sequences averaged 25%, and the
majority of the excluded sequences were background
sequences and eukaryote sequences (Supplementary file
SB). Thus, the number of vascular biopsies examined in
this group was limited to 10 randomly selected biopsies.
Renko et al. (47) using 16S rDNA sequencing, reported
the average number of different bacterial sequences from
atherosclerotic lesions in patients without signs of clinical
infections to be 2.291.2, which is comparable to our
patients without CP (2.891.6).
In subjects with CP, several common oral taxa were
detected in the vascular biopsies, i.e. Streptococcus,
Prevotella, Capnocytophaga, Veillonella, and Porphyro-
monas spp., while in patients without CP, only one
common oral taxon was found (Streptococcus sp.). These
species and other possible oral taxa detected in the
vascular biopsies are highlighted in Tables 4 and 5.
Although these taxa represent only a minor proportion
of the oral bacterial microbiota, the data suggest that
the oral cavity may be a potential source for bacterial
dissemination to vascular tissue. Due to the near absence
of RCB in vascular biopsies, we wanted to confirm their
presence in the subgingival plaque in CP patients by
using checkerboard DNADNA hybridization analysis.
Although this method cannot be compared to 16S rDNA
sequencing, it is an efficient and sensitive detection
method for this purpose (30). The checkerboard analysis
revealed presence of one to three members of the RCB in
7 out of 10 subgingival plaque samples from the CP
patients (Table 2). Further, only 3 out of 19 bacterial spp.
found in the subgingival plaque by checkerboard analysis
were detected in the vascular biopsies in the CP group
(i.e. P. gingivalis, Actinomyces sp., and Streptococcus
spp.), suggesting dissimilar bacterial composition in the
subgingival plaque and vascular biopsies. In a previous
study, 16S rDNA-based PCR was positive for bacterial
detection, whereas checkerboard DNADNA hybridiza-
tion methods were negative. This indicated that the
number of RCB-positive subgingival plaque samples in
our study could possibly be even higher (48).
Similarly, Nakano et al. (49) showed that the bacterial
composition in dental plaque was different from what
was found in cardiovascular specimens. The presence of
periodontopathogens and other oral bacterial species
were sparse in cardiovascular tissue, and only a few
species, including S. mutans, may have originated from
the oral cavity.
A relatively high percentage (15.4%) of the sequences
detected in vascular biopsies from patients with CP
belonged to the Enterobacteriaceae family, i.e. Serratia
sp. and Klebsiella sp. These and other enteric species
have been isolated from subgingival sites (50). In addi-
tion, enteric bacteria are known to be important noso-
comial pathogens, and it cannot be excluded that they
were transmitted to the patients through the hospital
environment (51). However, the highest load of Entero-
bacteriaceae is found as part of the gut microbiota. The
intestines harbor the largest number of bacterial cells in
the human body, making it likely that a major part of the
bacterial taxa detected in our vascular biopsies had
originated from the intestines. Several mechanisms for
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dissemination of gut bacteria into the blood stream have
been described (52). Koren et al. (45) found several
operational taxonomic units shared between the gut and
atherosclerotic plaque suggesting that bacteria present in
the atherosclerotic plaque could have been derived from
the gut. In a study by Hietbrink et al. (53), systemic
inflammation induced by intravenously administrated E.
coli lipopolysaccharide increased the intestinal perme-
ability which may facilitate bacterial translocation. Ani-
mal studies have shown inflammation to induce and
sustain increased intestinal permeability (54, 55). We may
hypothesize that low-grade chronic systemic inflamma-
tion caused by periodontal disease (56) may affect intes-
tinal permeability and thereby translocation of enteric
bacteria, dissemination to the bloodstream, and further
colonization of vascular lesions, as seen in our vascular
biopsies from patients with CP.
We detected DNA from as-yet-uncultured bacterial
taxa in both groups. Much of the human microbiota is
not yet cultivated (57), and the presence of different not-
yet-cultured bacterial taxa is to be expected. Their
significance for oral and cardiovascular disease remains
to be elucidated.
Several environmental bacterial species with unde-
fined pathogenicity were detected in the VD biopsies,
such as members of the families Chitinophagaceae and
Rhodobacteraceae, Geobacter sp., and Alishewanella sp.
Through the skin and mucous membrane linings of the
respiratory, gastrointestinal, and genitourinary tracts, the
human body is constantly exposed to environmental
species. Some of the environmental bacteria detected in
the VD biopsies may be part of our transient microbiota.
The inclusion of negative controls and the high level of
interindividual differences in detection of environmental
species make it unlikely that these bacterial taxa are
introduced by technical contamination. Several other
studies have reported the presence of environmental
species in vascular lesions and clinical samples (47, 58);
however, the pathogenicity and clinical relevance of most
environmental bacterial taxa in patient samples are yet to
be determined.
Bacterial DNA belonging to Pseudomonas sp. and
Propionibacterium acnes were frequently detected in both
groups of patients. Pseudomonas is an opportunistic
human pathogen of clinical relevance, and has been con-
sidered by some to be associated with periodontal disease
(59). P. acnes is part of the commensal microbiota of skin
and respiratory and digestive mucosa. This species is a
common blood contaminant and can be the cause of
postoperative infections, and has been associated with
different cases of apical periodontitis and endocarditis
(60, 61).
Acinetobacter sp. was found in both groups and was
among the most prevalent in the group with CP.
Acinetobacter has been isolated from periodontal pockets
(50), and is known to be a frequent cause of nosocomial
infections, especially pneumonias, as well as bloodstream
and urinary tract infections (62, 63). Streptococcus and
Staphylococcus spp. were detected in both groups. Non-
pathogenic streptococcal spp. are part of the commensal
microbiota of the mouth, skin, intestines, and upper res-
piratory tract. However, they can cause serious conditions
such as bacteremia, meningitis, and pneumonia, and have
been associated with endocarditis (64). Staphylococcus
spp., such as S. epidermidis and S. aureus, is part of the
commensal skin and respiratory tract microflora. Similar
to streptococci they can cause cardiovascular conditions
such as endocarditis (64).
By SEM, bacterial cells with different morphology
were detected in all examined specimens from CP
patients. Bacteria seemingly going through cell division
were also observed. These findings emphasize the pre-
sence of bacterial cells, not only bacterial DNA, in the
VD biopsies. Viable invasive bacteria such as P. gingivalis
and A. actinomycetemcomitans have been cultivated from
human atherosclerotic plaque (65, 66). Others have
suggested that bacteria from the circulation might get
caught in the vascular lesions as ‘innocent bystanders’
(67). However, animal studies have shown that bacterial
taxa such as Chlamydia pneumonia and P. gingivalis may
invade atherosclerotic plaque, alter inflammatory path-
ways, and cause molecular mimicry, and thereby may
contribute to the progression of atherogenesis (6, 13).
In conclusion, our results indicate that the cumulative
effect of different infectious agents may be associated
with the pathophysiology of atherosclerotic and abdom-
inal aortic aneurysmal vascular diseases. The infectious
burden seems to be associated with chronic periodontal
disease. However, periodontopathogens were rarely iden-
tified in the vascular biopsies, whilst gut bacteria were
detected more frequently. A possible association between
chronic periodontal disease, systemic inflammation, in-
testinal permeability, and enterobacterial colonization of
atherosclerotic and aneurysmal tissue should be studied
further.
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